Comparison of the sensitivity of commercial aPTT tests in measurement of the pharmacodynamic response of milvexian, a novel FXIa inhibitor
Event:
ESC Congress 2021 - The Digital Experience
Topic:
Anticoagulants
Session:
Pharmacology and pharmacotherapy e-posters
